These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 805027)

  • 21. [Adjuvant anorectic therapy--value and tolerance].
    Maibach E
    Med Welt; 1978 Aug; 29(32):1249-53. PubMed ID: 672595
    [No Abstract]   [Full Text] [Related]  

  • 22. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
    Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anorectic effectiveness of differing dosage forms of fenfluramine.
    Tisdale SA; Ervin DK
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
    [No Abstract]   [Full Text] [Related]  

  • 25. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice.
    Vallé-Jones JC; Brodie NH; O'Hara H; O'Hara J; McGhie RL
    Pharmatherapeutica; 1983; 3(5):300-4. PubMed ID: 6844367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Copenhagen PRODI project: preliminary results.
    Quaade F; Hyldstrup L; Andersen T
    Int J Obes; 1981; 5(3):263-6. PubMed ID: 7024155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 29. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of obesity: some recent concepts.
    Weinhaus RS
    Mo Med; 1969 Sep; 66(9):719-23 passim. PubMed ID: 4897933
    [No Abstract]   [Full Text] [Related]  

  • 31. Trial of a long-acting preparation of diethylpropion in obese diabetics.
    Williams J
    Practitioner; 1968 Mar; 200(197):411-4. PubMed ID: 4868835
    [No Abstract]   [Full Text] [Related]  

  • 32. Tenuate dospan as an appetitie suppressant in the treatment of obese children.
    Stewart DA; Bailey JD; Patell H
    Appl Ther; 1970 May; 12(5):34-6. PubMed ID: 4912482
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled clinical evaluation of a new anorectic agent in obese adults.
    Elmaleh MK; Miller J
    Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs.
    Dahms WT; Molitch ME; Bray GA; Greenway FL; Atkinson RL; Hamilton K
    Am J Clin Nutr; 1978 May; 31(5):774-8. PubMed ID: 417615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
    Galloway DB; Logie AW; Petrie JC
    Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 37. Diethylpropion in the treatment of obese patients seen in general practice.
    Matthews PA
    Curr Ther Res Clin Exp; 1975 Apr; 17(4):340-6. PubMed ID: 804381
    [No Abstract]   [Full Text] [Related]  

  • 38. A long-acting appetite suppressant drug studied for 24 weeks in both continuous and sequential administration.
    Le Riche WH; Csima A
    Can Med Assoc J; 1967 Oct; 97(17):1016-20. PubMed ID: 6052900
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice.
    Elliott BJ
    N Z Med J; 1978 Oct; 88(622):321-2. PubMed ID: 282482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of the use of a "false food" associated with an anorectic drug in the treatment of exogenous obesity].
    Manieri C; Biffignandi P; Molinatti GM
    Minerva Dietol Gastroenterol; 1979; 25(2):201-7. PubMed ID: 471302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.